评估中国鄞州老年人免费流感疫苗接种政策的有效性和成本效果:真实世界分析研究方案
本研究将利用鄞州健康信息系统(YHIS)建立2016至2021年65岁及以上常住老年居民的回顾性队列,估算疫苗接种覆盖率、流感发病率和流感相关直接医疗费用,使用回归断点设计评估2020/2021季节疫苗有效性,并构建决策树模型从社会和卫生系统角度比较免费三价流感疫苗、免费四价流感疫苗和无政策三种方案的成本效果,成本和质量调整生命年(QALYs)按每年5%贴现。
要点
- 研究基于鄞州健康信息系统建立2016至2021年65岁及以上老年居民回顾性队列。
- 将估算疫苗覆盖率、流感发病率及流感相关直接医疗费用。
- 用回归断点设计评估2020/2021季节疫苗有效性。
核心结论
- 本成本效果分析整合区域真实世界数据与文献,对政府资助的免费流感疫苗接种项目进行严格评估,结果预期为循证政策制定提供真实世界证据并促进老年人健康。
研究设计与样本
- 利用鄞州健康信息系统建立2016至2021年65岁及以上常住老年居民的回顾性队列。
- 使用回归断点设计估计2020/2021季节的疫苗有效性。
- 构建决策树模型,从社会和卫生系统角度比较免费三价流感疫苗、免费四价流感疫苗和无政策三种方案的成本效果。
- 参数输入来自鄞州健康信息系统和已发表文献。
- 计算增量成本效果比,成本和QALYs按每年5%贴现。
主要发现
- 将估算2016至2021年的疫苗覆盖率、流感发病率和流感相关直接医疗费用。
- 将估计2020/2021季节的疫苗有效性。
- 将比较三种流感疫苗接种方案的成本效果并计算增量成本效果比。
关键数值与推荐
- 研究对象为65岁及以上常住老年居民。
- 研究时间段为2016至2021年。
- 疫苗有效性评估季节为2020/2021季节。
- 成本和QALYs按每年5%贴现。
- 比较方案为免费三价流感疫苗、免费四价流感疫苗和无政策。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Influenza causes excessive morbidity and mortality among older adults. While influenza vaccine provides protection against its infection, the vaccination coverage in China among older adults has been very low. Previous evidence on the cost-effectiveness of government-sponsored free influenza vaccination programs in China was primarily based on literature data, which might not always reflect real-world patient populations. The Yinzhou Health Information System (YHIS) is a regional database that captures electronic health records, insurance claims data, etc. for all residents in Yinzhou district, Zhejiang province, China. We will use YHIS to study the effectiveness, influenza-related direct medical cost and cost-effectiveness analysis (CEA) of the free influenza vaccination program for older adults. In this paper, we describe the study design and innovations in detail. METHODS: We will establish a retrospective cohort of permanent older residents aged 65 and over, using YHIS between 2016 and 2021. We will estimate the vaccine coverage rate, influenza incidence rate and influenza-related direct medical cost from 2016 to 2021. Regression discontinuity will be used to estimate vaccine effectiveness for the 2020/2021 season. We will build a decision tree model to compare the cost-effectiveness of three influenza vaccination options (free trivalent influenza vaccine, free quadrivalent influenza vaccine, and no policy) from both societal and health system perspectives. Parameter inputs will be gathered from both YHIS and published literature. We will calculate the incremental cost-effectiveness ratio with cost and quality-adjusted life years (QALYs) discounted at 5 % annually. DISCUSSION: Our CEA solidifies multiple sources including regional real-world data and literature for a rigorous evaluation of the government-sponsored free influenza vaccination program. The results will provide real-world evidence from real-world data on the cost-effectiveness of a real-world policy. Our findings are expected to support evidence-based policy making and to promote health for older adults.
引用
- Zhang X, Shen P, Liu J, et al. Evaluating the effectiveness and cost-effectiveness of free influenza vaccination policy for older adults in Yinzhou, China: Study protocol of a real-world analyses. Vaccine. 2023. PMID: 37419850. doi:10.1016/j.vaccine.2023.06.087
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。